Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.54 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.54 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.36 |
| ▸ | MAPT | P10636 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | NQO2 | P16083 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6046956 | 0.85 | TXNRD1 (0.49) | TXNRD1TXNRD3TXNRD2KMT2AMAPT | |
| SCHEMBL1898972 | 0.83 | TXNRD1 (0.49) | TXNRD1TXNRD3TXNRD2KMT2AMAPT | |
| SCHEMBL15049954 | 0.82 | TXNRD1 (0.48) | TXNRD1TXNRD3TXNRD2KMT2AMAPT | |
| SCHEMBL3489697 | 0.81 | TXNRD1 (0.50) | TXNRD1TXNRD3TXNRD2KMT2AMAPT | |
| SCHEMBL17257753 | 0.78 | MAPT (0.54) | TXNRD1TXNRD3TXNRD2KMT2AMAPT | |
| SCHEMBL125664 | 0.78 | MAPT (0.54) | TXNRD1TXNRD3TXNRD2KMT2AMAPT | |
| SCHEMBL6054284 | 0.77 | TXNRD1 (0.55) | TXNRD1TXNRD3TXNRD2KMT2AMAPT | |
| SCHEMBL16724095 | 0.75 | TXNRD1 (0.52) | TXNRD1TXNRD3TXNRD2KMT2AMAPT | |
| SCHEMBL16722824 | 0.74 | TXNRD1 (0.51) | TXNRD1TXNRD3TXNRD2KMT2AMAPT | |
| SCHEMBL6038159 | 0.73 | TXNRD1 (0.56) | TXNRD1TXNRD3TXNRD2KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230092024-A1 | Increasing Efficiency Of Photochemical Reactions On Substrates | CENTRILLION TECHNOLOGIES, INC. | 2023-03-23 | — | — | US | claimed |
| US-20180149611-A1 | BIOSENSOR AND METHOD OF FORMING PROBE ON SOLID SURFACE OF BIOSENSOR | Caduceus Biotechnology Inc. (TW) | 2018-05-31 | — | — | US | claimed |
| US-20140142253-A1 | Dithiolane Based Thiol Modifier For Labeling and Stronger Immobilization of Bio-Molecules On Solid Surfaces | CHEMGENES CORPORATION (US) | 2014-05-22 | — | — | US | claimed |
| WO-2013126034-A1 | SYNTHESIS OF HIGH PURITY DMT-C3-DISULFIDE PHOSPHORAMIDITE | CHEMGENES CORPORATION (US) | 2013-08-29 | — | — | WO | claimed |
| US-7144700-B1 | Photolithographic solid-phase polymer synthesis | AFFYMETRIX, INC. (US) | 2006-12-05 | — | — | US | claimed |
| US-20230092024-A1 | Increasing Efficiency Of Photochemical Reactions On Substrates | CENTRILLION TECHNOLOGIES, INC. | 2023-03-23 | — | — | US | disclosed |
| WO-2021117680-A1 | BIOLOGICAL SUBSTANCE IMMOBILIZATION MATERIAL | 国立大学法人 東京大学 | 2021-06-17 | — | — | WO | disclosed |
| EP-3802847-A1 | INCREASING EFFICIENCY OF PHOTOCHEMICAL REACTIONS ON SUBSTRATES | Centrillion Technologies, Inc. (US) | 2021-04-14 | — | — | EP | disclosed |
| US-20200397901-A1 | PHOTORESPONSIVE SMOOTHENED LIGAND | THE UNIVERSITY OF TOKYO (JP) | 2020-12-24 | — | — | US | disclosed |
| US-10872924-B2 | Microarray and method for forming the same | Centrillion Technologies Taiwan Co. LTD. (TW) | 2020-12-22 | — | — | US | disclosed |
| US-20190165039-A1 | MICROARRAY AND METHOD FOR FORMING THE SAME | Centrillion Technologies Taiwan Co. LTD. (TW) | 2019-05-30 | — | — | US | disclosed |
| US-20180149611-A1 | BIOSENSOR AND METHOD OF FORMING PROBE ON SOLID SURFACE OF BIOSENSOR | Caduceus Biotechnology Inc. (TW) | 2018-05-31 | — | — | US | disclosed |
| US-20030013080-A1 | Complex multicellular assemblies ex vivo | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2003-01-16 | — | — | US | disclosed |
| US-20010049108-A1 | Methods for reducing non-specific binding to an oligonucleotide array | MCGALL GLENN (US) | 2001-12-06 | — | — | US | disclosed |
| US-6307042-B1 | GENERATING NUCLEOTIDE SEQUENCES; PROVIDE SUBSTRATE WAFERS, REMOVE PROTECTED GROUPS, TRANSFER SUBSTRATE WAFERS TO COUPLING STATION, TRANSFER SUBSTRATE WAFER TO ACTIVATION STATION, ANALYZE POLYMER LAYOUTS | AFFYMETRIX, INC. | 2001-10-23 | — | — | US | disclosed |
| EP-1071821-A1 | METHODS FOR REDUCING NON-SPECIFIC BINDING TO A NUCLEIC ACID PROBE ARRAY | Affymetrix, Inc. (a California Corporation) (US) | 2001-01-31 | — | — | EP | disclosed |
| WO-1999054509-A1 | METHODS FOR REDUCING NON-SPECIFIC BINDING TO A NUCLEIC ACID PROBE ARRAY | AFFYMETRIX, INC. (US) | 1999-10-28 | — | — | WO | disclosed |
| EP-0950112-A1 | PHOTOLABILE POLYMER ARRAY SYNTHESIS METHODS | Affymetrix, Inc. (a California Corporation) (US) | 1999-10-20 | — | — | EP | disclosed |
| US-5959098-A | ACTIVATING AND COUPLING MONOMERS IN DIFFERENT SELECTED ZONES OF SUBSTRATE FORMING DIFFERENT SEQUENCES IN DIFFERENT AREAS; ACTIVATING BY DIRECTING RADIATION AT SURFACE OF SUBSTRATE WITH FUNCTIONAL GROUPS PROTECTED BY PHOTOLABILE GROUPS | AFFYMETRIX, INC. (US) | 1999-09-28 | — | — | US | disclosed |
| WO-1997039151-A1 | PHOTOLABILE POLYMER ARRAY SYNTHESIS METHODS | AFFYMETRIX, INC. (US) | 1997-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142253-A1 | Dithiolane Based Thiol Modifier For Labeling and Stronger Immobilization of Bio-Molecules On Solid Surfaces | PTMS, SPOUT1, SRMS | TXNRD1 721/4885TXNRD3 667/4885TXNRD2 1045/4885 |
| US-20200397901-A1 | PHOTORESPONSIVE SMOOTHENED LIGAND | SMO, GLI1, SHH | TXNRD1 1702/4885TXNRD3 2202/4885TXNRD2 2409/4885 |
| US-20230092024-A1 | Increasing Efficiency Of Photochemical Reactions On Substrates | TYR, PCNA, DNMT1 | TXNRD1 2296/4885TXNRD3 302/4885TXNRD2 1299/4885 |
| US-20010049108-A1 | Methods for reducing non-specific binding to an oligonucleotide array | DCLRE1B, CD2BP2, NT5C3B | TXNRD1 1912/4885TXNRD3 717/4885TXNRD2 1430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.